Determination of anxiety, depression, and life satisfaction in lung cancer patients
Abstract
Background and aim of the work: This study aimed to determine the life satisfaction of patients with lung cancer by examining their levels of anxiety and depression. Methods: The study group consisted of 108 patients with lung cancer who were inpatients in a university hospital located in the Middle Black Sea region of Northern Turkey. The study was conducted between 28 March and 30 September 2013. Data were obtained using the Hospital Anxiety and Depression Scale (HADS) and Satisfaction with Life scale. Results: In this study, 3.7% of the patients were females, 96.3% were males, 96.3% were married, and 62.0% were primary school graduates. With regard to the disease stage, 40.7% were Stage 3. Among the group, 56.5% of the patients were receiving chemotherapy. In the patients, the treatment-related side effects were tiredness (78.7%), taste changes (68.5%), anorexia (65.7%), nausea (62.0%) vomiting (64.8%), and dyspnea (52.8%). According to the HADS scale, 97.2% of the patients had a risk of anxiety, and 100% had a risk of depression. The total score average of the patients on the Satisfaction with Life scale was 24.4±7.3. Conclusions: Almost all the patients had a risk of anxiety and depression. They were partially satisfied with their lives. They obtained relief from complementary and alternative treatments, such as biologically based therapies (herbs and dietary supplements) and mind-body control (prayer). The use of complementary and alternative treatments by lung cancer patients should be considered, as these may interfere with their prescribed treatment protocols.
Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.